相关实验视频
Updated: Jun 30, 2025

10:56
Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
12.0K
蛋白质降解系统在结直肠癌中的作用
Zihan Cui1, Mingqi Cong1, Shengjie Yin2
1Department of Pathology, Harbin Medical University, Harbin, 150081, China.
Cell death discovery
|March 15, 2024
概括
准无处不在蛋白酶体系统 (UPS) 和自-溶酶体系统同时显示出治疗结直肠癌 (CRC) 的希望. 了解这些蛋白质降解途径是澄清CRC机制的关键.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 蛋白质降解对细胞平衡至关重要,其中无处不在蛋白酶体系统 (UPS) 和自-溶酶体系统是主要的途径.
- 在管理高增殖癌细胞中的蛋白质过载时,UPS至关重要,包括结肠直肠癌 (CRC) 中的细胞.
研究的目的:
- 审查UPS和自溶酶体系统在结直肠癌 (CRC) 发病和进展中的双重作用.
- 阐明CRC中这些蛋白质降解途径之间的补偿关系.
- 突出同时针对 CRC 治疗的两种系统的治疗潜力.
主要方法:
- 在结肠直肠癌 (CRC) 中对全方位蛋白酶体系统 (UPS) 和自-溶酶体系统进行了全面的文献综述.
- 分析CRC病变发生过程中蛋白质降解途径和亡之间的相互作用.
- 在癌细胞中探索UPS和自之间补偿机制.
主要成果:
- UPS和自溶酶体系统在结直肠癌 (CRC) 的发展和进展中起着重要的,往往是补偿性的作用.
- 同时针对两种蛋白质降解途径,为CRC提供了一个有前途的治疗策略.
- 亡,无处不在和自是密切相关的,其中caspases介导蛋白质降解.
结论:
- 深入了解蛋白质降解途径之间的相互作用对于解开CRC机制至关重要.
- 双重抑制UPS和自为提高CRC治疗疗效提供了一种新的方法.
- 对这些途径的进一步研究可能会导致更有效的针对性治疗结直肠癌.
相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome
832
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
832
Proteins: From Genes to Degradation
12.2K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
12.2K
Regulation of Expression at Multiple Steps
904
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
904
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K

